Loachman said:
If I only knew who your recruiter was, I'd pay them good money to ask that question.
Well, at the very least it would give me a good story. Some of these myths are so strongly believed that they seem self-evident. I think his jaw would just drop open.
More than likely it won't come up. Hopefully it is so far in the past that it won't really matter. I have not used many drugs prohibited by the Controlled Drugs and Substances Act (CDSA) and most of that was 14 years ago or longer.
Jed: I'm not a climatologist. I think when it comes to climate the difficulty in making accurate predictions is that the Earth is not a simple system. Climate can reach a dynamic equilibrium and then become chaotic. It's hard to predict and models have to be constantly refined.
I like to argue, not in the sense of screaming back and forth at another person, but having a rational argument about something which we disagree on. I'm a bit iconoclastic maybe. It is unfortunate that funding sources can cause conflicts of interest and bias in science. Good scientists should always be trying to set up experiments that would prove their hypotheses wrong. Look at the pharmaceutical industry and how they don't have to disclose all of their data. A pharmaceutical firm could do 100 clinical trials on a drug they are developing and find that only 2 of those trials gave the results they want to see. They then only publish those 2 trials. I think that is dishonest: it is lying by omission.
Then, of course, some pharmaceutical firms do dishonestly market their products, such Pfizer's marketing of Neurontin (gabapentin) for unapproved (i.e. "off-label") uses. Or look at Purdue Pharma's dishonest marketing of Oxycontin, the time-release version of oxycodone. They claimed that their product would be less addictive than immediate release opioid drugs simply because it would not hit the user all at once. I don't know how MDs could have believed such a thing. Pharmaceutical chemists have been trying to separate the euphoric properties of opioids from their analgesic properties since the elucidation of morphine's structure, well over a century ago, and nobody has been successful. Any drug that acts as an agonist at the mu opioid receptor will cause analgesia and euphoria. Suddenly Purdue Pharma comes along and claims their powerful narcotic product might be less addictive just because it is a time release formulation. I just don't see how MDs could have believed that. Indiscriminate prescribing of Oxycontin has been a big part in causing the heroin epidemic that the USA (and Canada) are facing. Purdue Pharma paid a $600 million fine. I'm sure that's peanuts compared to the profit they made from Oxycontin which came on the market in 1996.
My apologies if this is too off-topic. I'm not trying to derail the thread.